Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 1,195 | 2,512 | 2,589 | 3,240 | 2,614 |
| Operating Income | -1,195 | -2,512 | -2,589 | -3,240 | -2,614 |
| Other Income | 63 | 79 | 106 | 167 | 165 |
| Pre-tax Income | -1,132 | -2,433 | -2,483 | -3,073 | -2,449 |
| Net Income Continuous | -1,132 | -2,433 | -2,483 | -3,073 | -2,449 |
| Net Income | $-1,132 | $-2,433 | $-2,483 | $-3,073 | $-2,449 |
| EPS Basic Total Ops | -0.35 | -0.75 | -0.78 | -0.99 | -0.83 |
| EPS Basic Continuous Ops | -0.35 | -0.75 | -0.78 | -0.99 | -0.83 |
| EPS Diluted Total Ops | -0.35 | -0.75 | -0.78 | -0.99 | -0.83 |
| EPS Diluted Continuous Ops | -0.35 | -0.75 | -0.78 | -0.99 | -0.83 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.75 | -0.78 | -0.99 | -0.83 |
| EBITDA(a) | $-1,195 | $-2,512 | $-2,589 | $-3,240 | $-2,614 |